Cue Biopharma, Inc. (CUE)
USD 1.07
(0.94%)
USD 1.07
(0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.96 Million | -41.8 Million | -38.83 Million | -32.49 Million | -30.79 Million | -26.41 Million |
| Net Income | -50.73 Million | -53.01 Million | -44.16 Million | -44.78 Million | -36.69 Million | -38.98 Million |
| Depreciation & Amortization | 3.43 Million | 1.8 Million | -1.77 Million | 1.05 Million | 5.16 Million | 760.01 Thousand |
| Deferred income taxes | -15.92 Million | - | - | 83.69 Thousand | -18.19 Thousand | 79.85 Thousand |
| Stock-based compensation | 8.18 Million | 9.49 Million | 11.51 Million | 10.48 Million | 6.52 Million | 7.17 Million |
| Change in working capital | -934 Thousand | 356.27 Thousand | -4.38 Million | 1.23 Million | -1.48 Million | 4.21 Million |
| Other non-cash items | 16.01 Million | -453.77 Thousand | -26.13 Thousand | -563.23 Thousand | -4.27 Million | 345.1 Thousand |
| Investing Cash Flow | 25 Million | -24.6 Million | 9.1 Million | 4.45 Million | 3.44 Million | -20.35 Million |
| Investments in PPE | - | -170.74 Thousand | -913.03 Thousand | -595.25 Thousand | -46.35 Thousand | -1.85 Million |
| Acquisitions | 2000.00 | 6205.00 | 4581.00 | 83.69 Thousand | 127.5 Thousand | - |
| Investment purchases | - | -29.44 Million | -4581.00 | -9.94 Million | -15.13 Million | -39.5 Million |
| Sales/Maturities of investments | 25 Million | 5 Million | 10 Million | 15 Million | 18.5 Million | 21 Million |
| Other Investing Activities | 25 Million | -24.43 Million | 21.55 Thousand | -83.69 Thousand | 3.49 Million | -18.5 Million |
| Financing Cash Flow | 11.86 Million | 53.65 Million | 19.23 Million | 58.61 Million | 50.78 Million | 4.18 Million |
| Debt repayment | -2 Million | -10 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -200 Thousand | -750.18 Thousand | -271.05 Thousand | -91.02 Thousand | - |
| Common Stock Issuance | 13.86 Million | 44 Million | 17.38 Million | 56.68 Million | 48.99 Million | 4.16 Million |
| Other Financing Activities | 13.86 Million | 43.85 Million | 2.59 Million | 2.2 Million | 1.88 Million | 12.5 Thousand |
| Accounts receivables | -1.64 Million | 3.08 Million | -1.72 Million | -662.58 Thousand | -754.89 Thousand | - |
| Accounts payables | 770 Thousand | 83.11 Thousand | 520.39 Thousand | 741.26 Thousand | -1.15 Million | 376.14 Thousand |
| Inventory | - | - | 4.79 Million | 4.85 Million | -509.79 Thousand | - |
| Other working capital | -63 Thousand | -2.81 Million | -7.97 Million | -3.69 Million | 928.58 Thousand | 3.83 Million |
| Cash at beginning of period | 51.61 Million | 64.52 Million | 75.01 Million | 44.44 Million | 21 Million | 63.58 Million |
| Cash at end of period | 48.51 Million | 51.76 Million | 64.52 Million | 75.01 Million | 44.44 Million | 21 Million |
| Capital Expenditure | - | -170.74 Thousand | -913.03 Thousand | -595.25 Thousand | -46.35 Thousand | -1.85 Million |
| Effect of forex changes on cash | -1102.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -3.1 Million | -12.75 Million | -10.49 Million | 30.57 Million | 23.43 Million | -42.58 Million |
| Free Cash Flow | -39.96 Million | -41.97 Million | -39.75 Million | -33.08 Million | -30.84 Million | -28.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.17 Million | -12.34 Million | -50.73 Million | -13.43 Million | -11 Million | -13.18 Million |
| Depreciation & Amortization | 866 Thousand | 849 Thousand | 3.43 Million | 851 Thousand | 856 Thousand | 849 Thousand |
| Deferred income taxes | - | - | -15.92 Million | -2.79 Million | 21 Thousand | -41 Thousand |
| Stock-based compensation | 1.75 Million | 1.94 Million | 8.18 Million | 2.07 Million | 2.07 Million | 2.03 Million |
| Change in working capital | -2.47 Million | -274 Thousand | -934 Thousand | -647 Thousand | 246 Thousand | -40 Thousand |
| Other non-cash items | 3.98 Million | 2.97 Million | 16.01 Million | 2.99 Million | 10 Thousand | 9000.00 |
| Investing Cash Flow | -10 Thousand | -55 Thousand | 25 Million | - | 5 Million | 5 Million |
| Investments in PPE | -10 Thousand | -55 Thousand | - | - | - | - |
| Acquisitions | - | - | 2000.00 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 25 Million | - | 5 Million | 5 Million |
| Other Investing Activities | - | - | 25 Million | - | 5 Million | 5 Million |
| Financing Cash Flow | -1 Million | 2.35 Million | 11.86 Million | 4.78 Million | 4.58 Million | 2.1 Million |
| Debt repayment | -1 Million | -1 Million | -2 Million | -1 Million | -1 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.35 Million | 13.86 Million | 5.78 Million | 5.58 Million | 2.01 Million |
| Other Financing Activities | - | 3.35 Million | 13.86 Million | 5.78 Million | 4.58 Million | 85 Thousand |
| Accounts receivables | -447 Thousand | 298 Thousand | -1.64 Million | -38 Thousand | -526 Thousand | -938 Thousand |
| Accounts payables | -13 Thousand | 418 Thousand | 770 Thousand | 1.02 Million | 124 Thousand | 205 Thousand |
| Inventory | - | - | - | 1.00 | 1.09 Million | 976 Thousand |
| Other working capital | -2.01 Million | -990 Thousand | -63 Thousand | -1.63 Million | -445 Thousand | -283 Thousand |
| Cash at beginning of period | 41.02 Million | 48.51 Million | 51.61 Million | 54.69 Million | 53.05 Million | 56.32 Million |
| Cash at end of period | 30.02 Million | 41.02 Million | 48.51 Million | 48.51 Million | 54.84 Million | 53.05 Million |
| Capital Expenditure | -10 Thousand | -55 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | -1102.00 | - | - | - |
| Net cash flow / Change in cash | -11 Million | -7.48 Million | -3.1 Million | -6.17 Million | 1.79 Million | -3.27 Million |
| Free Cash Flow | -10 Million | -9.83 Million | -39.96 Million | -10.95 Million | -7.79 Million | -10.37 Million |
2327
SCDA
BEKS
4076
ORA
MEXGF